Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZABAS
NCT04742010Phase 2Completed
- Start
- Feb 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in osteoporosis, muscle atrophy. Started Feb 2021; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosismuscle atrophy
Beyond the preview
Go deeper on NCT04742010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04742010.